Step 1 of 2
Psychotropic deprescribing is not simply about reducing medication burden, but about reassessing whether each treatment continues to provide meaningful benefit for the individual patient. This downloadable slideset uses real-world clinical dilemmas to examine when deprescribing, continuation, or optimization may be appropriate. It also highlights strategies for individualized risk–benefit assessment, shared decision-making, tapering, and follow-up for withdrawal or symptom recurrence.